For many women, perimenopause arrives as an unwelcome surprise.
A new Mira survey of 877 women using the Mira Hormone Monitor in menopause testing mode reveals not only the physical changes of this life stage, but also the emotional and social ripple effects—along with a striking gap in guidance.
What the Numbers Say
- Perimenopause is poorly explained. A majority (52%) of women said they were surprised by how little guidance they received from their doctor. Nearly half (46%) felt emotionally unprepared when symptoms began.
- Relationships feel the strain. 59% report more conflict and less intimacy with their partners. 77% feel their partners don’t understand what’s happening with them. Encouragingly, 1 in 3 women say friendships strengthened through shared experience.
- Parenting gets harder. 42% say perimenopause made parenting more difficult, often due to fatigue, stress, and lower patience.
- Loneliness is a huge hurdle. 1 in 3 women said feeling lonely was one of the hardest parts of perimenopause, describing it as an ongoing challenge rather than a passing feeling. 43% were misdiagnosed with anxiety or depression, while the root cause was hormonal.
- Women educate themselves. Half of women first heard the word “perimenopause” from social media or TV, while only 13% learned about it from family. Women are 5x times more likely to learn about perimenopause from AI and health tech tools like Mira than from their doctors.
These findings highlight an urgent need for better clinical education, family dialogue, and accessible tools so women can recognize and manage hormonal changes earlier.
The Broader Picture: Reinforcing the Need for Care
The insights from this fresh Mira survey reflect a broader, systemic challenge: many women continue to face confusion, isolation, and barriers when navigating perimenopause. Mira’s comprehensive 2025 Hormonal Health Report, conducted with 2,250 American women for Sex Hormones Awareness Day, puts this into sharper perspective.
- Awareness gaps are still significant. 4 in 10 American women haven’t heard of perimenopause (at all!)
- Delayed diagnosis. Half of women experiencing symptoms wait more than six months for a diagnosis.
- Education and guidance fall short. 73% of women feel that hormonal health education is insufficient, leaving many unsure whether their symptoms are serious enough to address—44% report feeling uncertain about the significance of their hormonal concerns.
- Practical and financial barriers add stress. 1 in 3 women avoid addressing hormonal health issues due to cost. 23% believe they cannot afford HRT, and another 33% are unsure.
- Communication gaps exist. 7 in 10 women feel they cannot share hormonal health struggles at work, and more than half (55%) don’t feel comfortable discussing their symptoms even with a partner.
- Lifestyle interventions often fall short. Nearly half (46%) of women who tried lifestyle adjustments—like diet, exercise, or stress management—felt that these changes were not effective in addressing their symptoms.
This reinforces that women need tools, guidance, and community to navigate perimenopause confidently, and Mira is working to provide all three.
From Data to Action: The We Do Care Community
All the numbers prove one thing: care isn’t optional—it’s critical.
To mark Menopause Awareness Day 2025 (October 18), Mira is launching the We Do Not Care Community campaign, a positive movement to replace silence with support.
Mira partnered with healthcare practitioners and trusted influencers to champion a simple message:
Your experience matters. Your data matters. You deserve care that is informed, personalized and empathetic.
Because care is non-negotiable.
Data Can Be a Lifeline: The Mira Hormone Monitor Menopause Kit
Launched just a year ago for Menopause Awareness Month 2024, the Mira Hormone Monitor Menopause Kit has already helped over 12,000 women take a proactive approach to peri/menopause clarity, by monitoring their hormones at home.
The Mira Monitor—trusted by over 200,000 worldwide for more than 8 years for fertility, hormonal imbalance, and cycle tracking—has now proven equally valuable for the menopause transition. It tracks four key hormones (FSH, E3G, PdG, and LH) with 99.5% lab-grade accuracy in the privacy of home.
Why it matters for women in perimenopause:
- Confidence in care: 9 in 10 users felt prepared to consult their doctor with concrete data.
- Peace of mind: 89% report reduced anxiety about menopause.
- Symptom insight: 71% connect daily hormone fluctuations to symptoms, and 77% find it helpful in HRT.
Mira meets international quality standards (ISO 13485, MDSAP, FDA registered) and was recognized in Fast Company’s World Changing Ideas 2025 list.
Moving Forward with Clarity
Perimenopause is not just a medical event, it’s a social and mental health turning point.
Accurate information, empathetic healthcare, and actionable data help women navigate it with confidence and control.
Whether you’re seeking better communication with your doctor, clarity about symptoms, or support for relationships and parenting, understanding your hormones is the first step toward feeling informed and empowered.
